153 related articles for article (PubMed ID: 29456733)
21. Molecular insights and clinical implications for the tumor suppressor role of SCF
Qi Y; Rezaeian AH; Wang J; Huang D; Chen H; Inuzuka H; Wei W
Biochim Biophys Acta Rev Cancer; 2024 Jun; 1879(5):189140. PubMed ID: 38909632
[TBL] [Abstract][Full Text] [Related]
22. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7.
Zhao J; Hu C; Chi J; Li J; Peng C; Yun X; Li D; Yu Y; Li Y; Gao M; Zheng X
Oncol Rep; 2016 Aug; 36(2):1143-9. PubMed ID: 27350307
[TBL] [Abstract][Full Text] [Related]
23. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
[TBL] [Abstract][Full Text] [Related]
24. Function and regulation of F-box/WD repeat-containing protein 7.
Zhang Z; Hu Q; Xu W; Liu W; Liu M; Sun Q; Ye Z; Fan G; Qin Y; Xu X; Yu X; Ji S
Oncol Lett; 2020 Aug; 20(2):1526-1534. PubMed ID: 32724394
[TBL] [Abstract][Full Text] [Related]
25. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
[TBL] [Abstract][Full Text] [Related]
26. TMSB10 promotes migration and invasion of cancer cells and is a novel prognostic marker for renal cell carcinoma.
Xiao R; Shen S; Yu Y; Pan Q; Kuang R; Huang H
Int J Clin Exp Pathol; 2019; 12(1):305-312. PubMed ID: 31933746
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive Study of Human FBXW7 Deleterious nsSNP's Functional Inference and Susceptibility to Gynaecological Cancer.
Vasuki KA; Christy HJ
Appl Biochem Biotechnol; 2022 Jan; 194(1):407-433. PubMed ID: 34817806
[TBL] [Abstract][Full Text] [Related]
28. FBXW7 attenuates tumor drug resistance and enhances the efficacy of immunotherapy.
Chen S; Lin J; Zhao J; Lin Q; Liu J; Wang Q; Mui R; Ma L
Front Oncol; 2023; 13():1147239. PubMed ID: 36998461
[TBL] [Abstract][Full Text] [Related]
29. FBXW7 acts as an independent prognostic marker and inhibits tumor growth in human osteosarcoma.
Li Z; Xiao J; Hu K; Wang G; Li M; Zhang J; Cheng G
Int J Mol Sci; 2015 Jan; 16(2):2294-306. PubMed ID: 25622249
[TBL] [Abstract][Full Text] [Related]
30. SCF
Sugiyama S; Yumimoto K; Inoue I; Nakayama KI
Genes Cells; 2019 May; 24(5):354-365. PubMed ID: 30838725
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Fbxw7 expression and its correlation with the expression of c-Myc, cyclin E and p53 in human hepatocellular carcinoma.
Tu K; Zheng X; Zan X; Han S; Yao Y; Liu Q
Hepatol Res; 2012 Sep; 42(9):904-10. PubMed ID: 22548670
[TBL] [Abstract][Full Text] [Related]
32. miR-92b-3p Promotes Colorectal Carcinoma Cell Proliferation, Invasion, and Migration by Inhibiting FBXW7 In Vitro and In Vivo.
Gong L; Ren M; Lv Z; Yang Y; Wang Z
DNA Cell Biol; 2018 May; 37(5):501-511. PubMed ID: 29638162
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
[TBL] [Abstract][Full Text] [Related]
34. Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer.
Gasca J; Flores ML; Giráldez S; Ruiz-Borrego M; Tortolero M; Romero F; Japón MA; Sáez C
Oncotarget; 2016 Aug; 7(33):52751-52765. PubMed ID: 27409838
[TBL] [Abstract][Full Text] [Related]
35. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
[TBL] [Abstract][Full Text] [Related]
36. Loss of FBXW7 is related to the susceptibility and poor prognosis of cervical squamous carcinoma.
Xu Y; Yu J; Liu T; Meng F; Kong D; Lou G
Biomarkers; 2016; 21(4):379-85. PubMed ID: 26954701
[TBL] [Abstract][Full Text] [Related]
37. Expression levels of FBXW7 and MDM2 E3 ubiquitin ligases and their c-Myc and p53 substrates in patients with dysplastic nevi or melanoma.
Mozuraitiene J; Gudleviciene Z; Vincerzevskiene I; Laurinaviciene A; Pamedys J
Oncol Lett; 2021 Jan; 21(1):37. PubMed ID: 33262829
[TBL] [Abstract][Full Text] [Related]
38. RUNX3 regulates renal cell carcinoma metastasis via targeting miR-6780a-5p/E-cadherin/EMT signaling axis.
Chen F; Liu X; Cheng Q; Zhu S; Bai J; Zheng J
Oncotarget; 2017 Nov; 8(60):101042-101056. PubMed ID: 29254144
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting
Ji S; Su X; Zhang H; Han Z; Zhao Y; Liu Q
Oncol Lett; 2019 Feb; 17(2):2400-2408. PubMed ID: 30719113
[TBL] [Abstract][Full Text] [Related]
40. Knockdown of NSD2 Suppresses Renal Cell Carcinoma Metastasis by Inhibiting Epithelial-Mesenchymal Transition.
Han X; Piao L; Yuan X; Wang L; Liu Z; He X
Int J Med Sci; 2019; 16(10):1404-1411. PubMed ID: 31692936
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
